Peptides studied across the HPG axis and CNS sexual-response pathways.
This area covers peptides acting on the central and endocrine control of sexual and reproductive function. Two pathways dominate the literature: central melanocortin signaling, studied for sexual-response disorders, and kisspeptin signaling, the upstream regulator of the hypothalamic–pituitary–gonadal (HPG) axis.
Endpoints range from hypoactive sexual desire disorder (HSDD) and CNS-mediated arousal to reproductive-endocrine applications such as hypothalamic amenorrhea and the study of puberty. Because these peptides act centrally and on hormone cascades, dose timing and feedback regulation are key research variables.
Two dominate the literature: central melanocortin signaling, studied for sexual-response disorders, and kisspeptin signaling, the upstream regulator of the HPG axis.
Research contexts include hypoactive sexual desire disorder (HSDD), CNS-mediated arousal, hypothalamic amenorrhea, and the study of puberty.
Because these peptides act centrally and on hormone cascades, timing and feedback regulation strongly influence the response observed in studies.
How to weigh this evidence
Preclinical, observational, and randomized findings carry very different weight. The evidence hierarchy shows how to rank what you read before drawing conclusions.